Cabaletta Bio, Inc.
CABA
$1.21
$0.054.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 32.23M | 28.69M | 26.81M | 24.05M | 22.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 125.14M | 114.50M | 100.12M | 85.74M | 74.66M |
| Operating Income | -125.14M | -114.50M | -100.12M | -85.74M | -74.66M |
| Income Before Tax | -115.86M | -104.16M | -89.98M | -76.87M | -67.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -115.86 | -104.16 | -89.98 | -76.87 | -67.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -115.86M | -104.16M | -89.98M | -76.87M | -67.68M |
| EBIT | -125.14M | -114.50M | -100.12M | -85.74M | -74.66M |
| EBITDA | -123.43M | -112.92M | -98.61M | -84.28M | -73.23M |
| EPS Basic | -2.34 | -2.15 | -1.90 | -1.71 | -1.65 |
| Normalized Basic EPS | -1.46 | -1.34 | -1.19 | -1.07 | -1.03 |
| EPS Diluted | -2.34 | -2.15 | -1.90 | -1.71 | -1.65 |
| Normalized Diluted EPS | -1.46 | -1.34 | -1.19 | -1.07 | -1.03 |
| Average Basic Shares Outstanding | 198.35M | 193.62M | 188.12M | 177.84M | 163.99M |
| Average Diluted Shares Outstanding | 198.35M | 193.62M | 188.12M | 177.84M | 163.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |